🧬 Aging Wiki

Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin

8 min read

Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin

Velarde MC, Flynn JM, Day NU, Melov S, Campisi J — Aging (Albany NY) 2012;4(1):3–12

TL;DR

Mitochondrial superoxide dismutase ( MnSOD) deficiency in mouse skin recapitulates key hallmarks of aged skin — p16^INK4a accumulation, nuclear DNA damage, impaired mitochondrial complex II activity, epidermal thinning, and increased terminal differentiation — without triggering apoptosis. Natural aging in C57BL/6J mice shows a parallel decline in mitochondrial complex II activity. In culture, mitochondrial ETC complex I inhibition (rotenone) induces senescence in human keratinocytes at lower doses than in dermal fibroblasts, placing the epidermis rather than the dermis as the primary site of mtROS-induced senescent-cell accumulation. Together the data argue that mitochondrial oxidative stress is a driver — not merely a correlate — of cellular senescence and skin aging phenotypes in vivo. Wrinkled appearance is not described in this paper and should not be attributed to it.

Background

cellular-senescence can be triggered by DNA damage, telomere shortening, oncogene activation, or oxidative stress. The mitochondrial-dysfunction hallmark posits that accumulation of mitochondrial reactive oxygen species (mtROS) drives progressive molecular damage during aging. However, direct in-vivo causal evidence linking mtROS to senescent-cell accumulation in a tissue context was limited at the time of publication.

sod2 (MnSOD) is the primary scavenger of superoxide generated at the inner mitochondrial membrane by complexes I and III. Homozygous deletion is lethal within days of birth 1, requiring neonatal rescue or tissue-specific inactivation for adult studies. This paper used a partial-rescue model (EUK-189, a synthetic SOD/catalase mimetic) to extend survival of Sod2-/- animals into early adulthood, enabling skin phenotyping.

The skin is a useful tissue for senescence biology: it is large, accessible, stratified (epidermis vs. dermis), and displays measurable aging phenotypes (thinning, altered differentiation) amenable to histological quantification. Predominant senescent cell types in this study are epidermal, not dermal fibroblasts — a point with implications for targeting strategies in skin aging.

Methods summary

In-vivo: Sod2-/- mouse model

  • Strain: CD1 background; homozygous Sod2 null (Sod2-/-)
  • Rescue: EUK-189 (synthetic SOD/catalase mimetic) at 1 mg/kg/day, administered from postnatal day 3 as maintenance throughout the experiment
  • Harvest age: 17–20 postnatal days
  • Groups for histology (SA-βgal, H&E, IHC): n=8 WT, n=9 KO (CD1)
  • Groups for SOD2-confirmation Western (Fig 2A): n=8 WT, n=9 KO (CD1)
  • Groups for senescence Westerns (p16^INK4a, ÎłH2AX, PARP/CASP3): n=6 WT, n=6 KO (CD1)
  • Clonogenicity assay: n=3 WT, n=3 KO
  • Endpoints: SA-β-gal activity (stratum corneum); p16^INK4a and p21^CIP1 protein (Western blot); ÎłH2AX foci (nuclear DNA damage); mitochondrial complex II (succinate dehydrogenase) activity; Ki-67 proliferation index; keratin 10 (terminal differentiation marker); epidermal thickness; stratum corneum thickness

In-vivo: natural aging cohort (C57BL/6J)

  • Strain: C57BL/6J; three age groups: n=6 at 4 months, n=10 at 8 months, n=13 at 24 months
  • Endpoints: SA-β-gal; p16^INK4a; mitochondrial complex II activity
  • These n’s must NOT be conflated with the Sod2-/- experiment groups above

In-vitro: rotenone-induced senescence

  • Cell lines: AG21837 (human neonatal keratinocytes); HCA2 (human foreskin fibroblasts)
  • Perturbation: rotenone (complex I inhibitor), 0–200 nM dose range; proliferation assessed at 4 days; SA-βgal assessed at 9 days; key comparison at 100 nM
  • Endpoint: SA-β-gal+ fraction (quadruplicate measurements); population doublings over 4 days
  • Statistical test: Student’s t test; all measurements in quadruplicates

In-vivo findings: Sod2-/- skin phenotype

Senescence markers elevated in Sod2-/- epidermis

Sod2-/- mouse skin showed two-fold higher p16^INK4a protein relative to WT littermates — this is the explicit text quote from the paper (“p16INK4a protein levels were two-fold higher in Sod2-/- relative to WT skin”) — Western blot, n=6/group 2. SA-β-gal activity was detectable in the stratum corneum of all 9 Sod2-/- mice examined (9/9 penetrance), whereas only minimal activity was observed in 1 of 8 WT mice (stratum corneum specificity confirmed; p<0.05 by Fisher Exact test). The senescent cells were localized to the epidermis, not the dermis — consistent with the greater rotenone sensitivity of keratinocytes demonstrated in vitro (see below).

p21^CIP1 protein was also elevated in Sod2-/- skin, though the paper’s primary CDK-inhibitor marker for the senescence phenotype is p16

Nuclear DNA damage without apoptosis

γH2AX foci (double-strand break marker) were increased in Sod2-/- epidermis, consistent with mtROS-driven nuclear DNA damage as an upstream trigger of the p16^INK4a induction. Crucially, the increase in p16^INK4a was not accompanied by elevated apoptosis — the cells are arrested/senescent rather than eliminated, directly paralleling the accumulation model of senescent cells in aged tissue 2.

Mitochondrial complex II activity impaired

Complex II (succinate dehydrogenase) activity was reduced in Sod2-/- skin relative to WT — establishing that mtROS impairs the ETC in this model, not merely correlates with it 2.

Epidermal structural changes

Histologically, Sod2-/- skin showed (n=8 WT / n=9 KO):

  • Reduced epidermal cell number and decreased epidermal thickness
  • Increased stratum corneum thickness (hyperkeratosis pattern)
  • Reduced Ki-67+ proliferating cells (consistent with senescence-mediated proliferative arrest)
  • Elevated keratin 10 (marker of terminal differentiation), suggesting premature commitment to differentiation at the expense of basal layer renewal

No “wrinkled appearance” is described in this paper. unsourced if claimed elsewhere without independent citation.

Natural aging cohort findings (C57BL/6J)

In naturally aged C57BL/6J mice, both p16^INK4a accumulation and SA-β-gal positivity increased progressively with age (4 → 8 → 24 months; n=6, 10, 13 respectively) 2. In parallel, mitochondrial complex II activity declined with age in the same cohort, mirroring the complex-II impairment observed in Sod2-/- skin and implicating the same enzymatic node across models. This convergence between the genetic-deficiency model and natural aging is a key internal consistency argument of the paper.

DimensionStatus
Pathway conserved in humans?yes (SOD2, complex II, p16^INK4a all conserved)
Phenotype conserved in humans?partial — epidermal thinning and p16+ accumulation occur in aged human skin; direct mtROS-causal evidence lacking in vivo
Replicated in humans?no needs-human-replication

In-vitro findings: keratinocyte vs. fibroblast rotenone sensitivity

Human neonatal keratinocytes (AG21837) treated with 100 nM rotenone for 9 days showed approximately ~80% SA-β-gal+ cells, versus approximately ~55% SA-β-gal+ for human dermal fibroblasts (HCA2) at the same dose — both significantly elevated over vehicle controls (Supplementary Fig 1B; quadruplicate measurements; p<0.05 by Student’s t test) 2. Both cell types showed significant reductions in population doubling at ≥20 nM rotenone over 4 days (Supp Fig 1A). This differential SA-βgal induction places keratinocytes as the more vulnerable cell type to complex-I-driven mtROS, consistent with the predominantly epidermal localization of senescent cells in the Sod2-/- in-vivo model.

Mechanistic model proposed

The paper’s proposed causal chain:

  1. Elevated superoxide at the inner mitochondrial membrane (whether from Sod2 loss or ETC dysfunction in natural aging)
  2. Oxidative damage to nuclear DNA → γH2AX foci
  3. p16^INK4a/CDK4/6-Rb axis activation → stable cell-cycle arrest
  4. Senescent cells accumulate in epidermis → reduced proliferative renewal → epidermal thinning + increased terminal differentiation

This connects the mitochondrial-dysfunction hallmark directly to the cellular-senescence hallmark via the dna-damage-response pathway, with the p16^INK4a → Rb arm as the effector. See also p53-pathway and p21 for the parallel p53/p21 arm of senescence enforcement.

The sasp is not analyzed in depth in this paper; the focus is on cell-intrinsic senescence markers.

Limitations

  1. Rescue model caveats. EUK-189 is not physiological; it may partially rescue non-SOD2-related phenotypes or incompletely rescue others, potentially confounding the Sod2-/- phenotype interpretation.
  2. CD1 background for KO, C57BL/6J for aging cohort. The two in-vivo arms use different genetic backgrounds. Effect sizes and senescence dynamics may differ by strain.
  3. No in-vivo human data. All causal evidence for mtROS → senescence is in mice or cell culture. Direct measurement of mtROS-induced p16+ accumulation in human dermis/epidermis in vivo is absent. needs-human-replication
  4. SA-β-gal in stratum corneum. The stratum corneum is a terminally differentiated, anucleate layer; SA-β-gal positivity in this compartment requires careful interpretation relative to the granular/spinous layers where nucleated senescent cells would reside.
  5. Rotenone in-vitro vs. physiological mtROS. Rotenone inhibits complex I at pharmacological concentrations; it is unclear whether the dose used (100 nM) approximates the superoxide flux generated by Sod2 deficiency or natural aging in the same cells.
  6. n-sizes. Histology at n=8–9 and Western at n=6 per group are standard for this era and organism model; statistical power to detect modest effect sizes is limited.
  7. Skin aging scope. Skin aging involves multiple processes beyond mtROS and senescence (UV damage, collagen cross-linking, ECM remodeling). The paper explicitly addresses only the mtROS–senescence axis.

Significance

This paper was among the first to demonstrate in-vivo that mtROS drives cellular senescence accumulation in a specific tissue (skin epidermis), using a genetically tractable model with internal consistency to the natural-aging trajectory. It directly links two hallmarks — mitochondrial-dysfunction and cellular-senescence — with mechanistic evidence rather than correlation, and positions the epidermal keratinocyte as the primary cellular substrate for this process in skin.

The 276 citations (OpenAlex) and 100th citation-percentile (FWCI 12.8) reflect substantial downstream influence in the skin-aging, senescence, and mitochondrial-ROS literature.

For downstream signaling from senescent epidermal cells, see sasp and altered-intercellular-communication. For the broader mtROS-aging hypothesis context, see mitochondrial-dysfunction and free-radical-theory-of-aging.

Footnotes

Footnotes

  1. doi:10.1038/ng1295-376 · Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ · Nat Genet 1995;11:376–381 · dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase; establishes necessity of SOD2 for early survival · in-vivo · model: Sod2-/- (strain not specified in Velarde 2012 citation) ↩

  2. velarde-2012-mitochondria-skin-senescence · Sod2-/- histology/SOD2-Western n=8 WT/9 KO; senescence Westerns (p16/γH2AX/PARP/CASP3) n=6 WT/6 KO; clonogenicity n=3/3; aging cohort n=6/10/13 at 4/8/24mo; in-vitro keratinocyte/fibroblast quadruplicates · in-vivo + in-vitro · model: CD1 Sod2-/- mouse (17–20 days postnatal) + C57BL/6J aging cohort + human AG21837 keratinocytes + HCA2 fibroblasts ↩ ↩2 ↩3 ↩4 ↩5

Graph View

Backlinks